Navigation Links
Telik Announces New TRAP Drug Discovery Agreement
Date:11/12/2008

olecules and to optimize these structures into new drug candidates.

About Telik

Telik, Inc. of Palo Alto, CA, is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.

Forward Looking Statements

This press release contains "forward-looking" statements, including statements regarding the potential application and capabilities of TRAP, and the potential utility of TRAP to HSS' drug discovery efforts. These forward-looking statements are based upon Telik's current expectations. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended September 30, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA, and TRAP are trademarks or registered trademarks of Telik, Inc.


'/>"/>
SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Telik Announces Financial Results for 2008 Third Quarter
2. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
3. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
4. Telik Announces Receipt of Nasdaq Notice
5. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
6. ReceptorBio Announces Diabetes License Agreement With Telik
7. Telik Announces Financial Results For 2008 Second Quarter
8. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
9. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
10. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
11. Telik Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  United Therapeutics Corporation (NASDAQ: ... release its second quarter 2014 financial results before ... United Therapeutics will host a half-hour teleconference ... Eastern Time.  The teleconference is accessible by dialing ... of the teleconference will be available for one ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Biofeedback ... hyperactivity disorder (ADHD) is diagnosed, selecting medication to best ... error. Analyzing brain patterns by using electroencephalography (EEG) can ... and thus lower the risk of adverse drug events. ... and Biomarkers” in the current issue of the ...
(Date:7/21/2014)... Lawrence Livermore National Laboratory ... Las Positas College (LPC) recently established a 24-month ... training for veterans, officials recently announced. , The ... is designed to help veterans develop the ... and establishes a pipeline of qualified candidates for ...
(Date:7/21/2014)... of Arts and Sciences has received a major ... , Mathew M. Maye, associate professor of chemistry, ... the National Science Foundation (NSF). The award supports ... the results of which may impact gas storage, ... , Maye,s approach is novel, in that he ...
Breaking Biology Technology:Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2
... Researchers at Duke University Medical Center, Beth Israel Deaconess ... to HIV vaccine design that uses an altered form of ... researchers showed that they could design HIV envelopes that could ... enhanced immune response in an animal model. Immature B cells ...
... new paradigm in quantum information processing has been demonstrated ... published in this week,s issue of Science Express ... integrated circuit that implements the quantum von Neumann architecture. ... can be programmed using a quantum central processing unit, ...
... Md., Sept. 1, 2011 Neuralstem, Inc. (NYSE Amex: ... Richard Garr will present at the 2011 Stifel Nicolaus ... a.m. EDT. Garr will discuss the Company,s opportunities and ... and will be providing an update on the ongoing ...
Cached Biology Technology:New HIV vaccine approach targets desirable immune cells 2New HIV vaccine approach targets desirable immune cells 3Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 2Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 3
(Date:7/21/2014)... 21, 2014 (Toronto) As part of a multinational, ... Mental Health (CAMH) have helped identify over 100 locations ... developing schizophrenia, in what is the largest genomic study ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
(Date:7/21/2014)... seals, every movement, researchers have shown for the first ... wind farms and pipelines. Those man-made structures probably serve ... a study published in the Cell Press journal ... was shocked when I first saw the stunning grid ... offshore wind farm in the United Kingdom, says Deborah ...
(Date:7/21/2014)... A University of California, San Diego School of Medicine-led ... not recognize the potentially serious health consequences of childhood ... in helping their child reach a healthy weight. , ... of the Academy of Nutrition and Dietetics . , ... and physical activity behaviors," said lead author Kyung Rhee, ...
Breaking Biology News(10 mins):International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3Seals forage at offshore wind farms 2Parents rank their obese children as 'very healthy' 2
... activated when we choose to suppress an emotion, compared to ... new study from the UCL Institute of Cognitive Neuroscience and ... Brain Structure and Function , the researchers scanned the brains ... activated when choosing for oneself to suppress an emotion. They ...
... among a national group of 87 newly elected fellows ... Tweten, OU Health Sciences Center in Oklahoma City, and ... highly-selective, peer-review process, based on their records of scientific ... Tweten, George Lynn Cross Research Professor in the Department ...
... that R. Graham Cooks, the Henry Bohn Hass Distinguished ... of the 2013 Dreyfus Prize in the Chemical Sciences, ... awarded biennially, consists of $250,000, a citation, and a ... University in the fall and will feature a lecture ...
Cached Biology News:Study finds brain system for emotional self-control 2OU microbiologists elected as fellows in the American Academy of Microbiology 2R. Graham Cooks wins Dreyfus Prize in the Chemical Sciences 2
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
ANTI S. GROUP AG:H...
Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
Biology Products: